Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
461studies shown
Showing 409-420 of 461
Behavioral study icon
SuspendedNCT02108899

Retrieval Practice and Schizophrenia

This study has public registry information. It focuses on schizophrenia and currently lists study information in France.

In France
SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
Device study icon
CompletedNCT02204254

RosaC-RF : Bipolar Radiofrequency vs Doxycycline in Rosacea

This study is completed. It focuses on bipolarity and currently lists study information in France.

In France
BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 70 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nice
Condition
Bipolarity
Other study type icon
CompletedNCT07034313

Rouen Study on Anxiety

This study is completed. It focuses on anxiety and currently lists study information in France.

In France
AnxietyOtherOver 18 Years
Countries
France
Sponsor
University Hospital, Rouen
Condition
Anxiety
Drug study icon
TerminatedNCT01674010

Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolarity type I

This study has public registry information. It focuses on bipolarity and currently lists study information in Bulgaria, Canada, Czech Republic, France, Poland, Romania, Spain, Turkey, and the United States.

In France
BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, France, Canada, ...
Sponsor
OPKO Health, Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT00280566

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolarity type I (Manic or Mixed)

This study is completed. It focuses on bipolarity and currently lists study information in Chile, France, Germany, Guatemala, China, India, Italy, Mexico, Russian Federation, Spain, Taiwan, the United States, and Venezuela.

In France
BipolarityDrugOver 18 Years
Countries
United States, France, Chile, ...
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT03238326

Open-Label Flexible-dose Brexpiprazole for schizophrenia

This study is completed in the United States, in France, in Italy, .... It is testing Open-Label Flexible-dose Brexpiprazole for schizophrenia.

In France
SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States, France, Italy, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT04436757

Self and Body-esteem in Socio-professional Rehabilitation

This study is completed. It focuses on depression and currently lists study information in France.

In France
Depression, Schizophrenia, ...BehavioralFrom 18 Years to 65 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Depression, Schizophrenia, ...